The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Baxter International Inc.  (BAX) Trade Now »     Rate BAX  -  Discuss BAX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
84.0%
Top:
100.0%
Rate BAX:



BAX Analysis & Videos »


BAX: Bull or Bear?

Baxter (BAX): Bank on blood products Graphic_rating_buy BAX
+2.12%
in 12 days

Filed under: Baxter Intl (BAX), Stocks to Buy

"Baxter International (BAX) benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates," says blue chip advisor Richard Moroney in Dow Theory Forecasts.

The advisor explains, "The ???rst company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical products since 1931. It primarily works with blood and plasma, a business with recession-resistant tendencies.

<>"Its BioScience unit produces clotting agents for hemophilia and biotech drugs that treat both immune de???ciencies ...
By  Steven Halpern   (+5.39%  risk: moderate)  11/24/09 Comment


Turnaround expert targets laggard pharmaceuticals Graphic_rating_buy BAX
-4.67%
in 43 days
(closed on 11/24/09)

Filed under: Newsletters, Abbott Laboratories (ABT), Baxter Intl (BAX), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Stocks to Buy

"Being contrarians, we are always looking for laggard stocks with the potential to rebound," says turnaround expert George Putnam.

In his The Turnaround Letter, the advisor reviews four medical and pharmaceutical stocks that have been among the worst performers in the S&P 100 since the market bottom. Despite their poor performance, he thinks they may be due for a rebound.

<>"We think that investors who got left behind by the first leg of the market rally are s...
By  Steven Halpern   (+5.39%  risk: moderate)  10/12/09 Comment


Consider Baxter: Its products don't go out of style Graphic_rating_buy BAX
+4.28%
in 141 days

Filed under: Stocks to Buy

I'm reiterating my Buy rating for Baxter (NYSE: BAX) first recommended on March 13, 2009 at a price of $51.16.

Baxter's near-recession-proof story remains intact. Baxter, a maker of a variety of medical products across three divisions, including drugs and vaccines, dialysis equipment, and IV supplies, should record a FY2009 revenue increase of 2-4%, led by demand for recombinants, plasma proteins, and antibody therapies in its bioscience unit.

Continue reading Consider Baxter: Its products don't go out of style

<>Consider Baxter: Its products don't go out of style orig...
By  Joseph Lazzaro   (+1.61%  risk: moderate)  07/18/09 Comment


Get free stock alert for BAX:
Your Email Address:


Javelin Pharma: Late-Stage Pipeline Targets Pain Graphic_rating_buy BAX
Mikerun
73%
 +9.67%
in 266 days
Javelin Pharma: Late-Stage Pipeline Targets Pain
 
Javelin Pharma (JAV) is focused on the late stage clinical development of three Phase 3 compounds while seeking partnerships for a non-dilutive source of funding. In mid-January, JAV established a partnership for Dyloject (injectable diclofenac) with Therabel Pharma to market the drug in Europe, where it is already approved for use.
 
 
<> The deal is worth up to $71M (with $12M in upfront cash and $59.5M in sales/regulatory milestones) and extends Javelin'...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/15/09 Comment


Baxter is one company that's on the mend Graphic_rating_buy BAX
+7.50%
in 127 days
(closed on 07/18/09)

Filed under: Baxter Intl (BAX), Stocks to Buy

Baxter HomeThe Dow's difficult start in 2009, following on the heels of 2008's awful performance, has done little to attract new money into the market. And neither has the U.S. economy, which remains entrenched in a pronounced recession, with few signs that it's bottomed.

The economic conditions invalidate most sectors, but there are a few that offer promise. One is health care, which is why Baxter International (NYSE: BAX) is worth a review.

Continue reading Baxter is one company that's on the mend

<>Baxter is one company that's on the mend originally appeared...
By  Joseph Lazzaro   (+1.61%  risk: moderate)  03/13/09 Comment


ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices? Graphic_rating_buy BAX
Mikerun
73%
 -13.49%
in 122 days
(closed on 03/15/09)

ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?

<>
<> The accompanying table includes statistics and the top five rated companies in the ETFI Global Health Innovators Index of companies with market caps over $100M which received FDA approval in the trailing 12-month period for either an original new drug or medical device product. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding reformulations of existing drugs, generic drugs, and label extensions for existing produc...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/12/08 Comment


Expanding Defensive Growth Index into Europe Graphic_rating_buy BAX
Mikerun
73%
 +0.12%
in 20 days
(closed on 11/12/08)

Expanding Defensive Growth Index into Europe

<>
<> The accompanying table presents an updated version of the ETFI Highly Defensive PerformIdex, which is expanded to 40 companies with market caps of at least $10B from the industry groups listed below. This defensive growth index is heavily weighted in consumer staples and healthcare and is now structured to include companies based in Europe, in addition to the United States and Canada.

Compared to the previous version, this index has a lower beta and higher average market cap and adds European companie...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/23/08 Comment


Bullish on BAX ... Graphic_rating_buy BAX
Foto
62%
 -13.61%
in 511 days
Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $70 Analysts' Targets Leerink Swann & Company $70 Outperform Monday, June 23, 2008 Baxter International, Inc. operates as a healthcare company worldwide. It offers medical devices, pharmaceuticals, and biotechnology products for the treatment of hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. The BioScience segment manufactures ...
By  Marian Filo   (-24.55%  risk: aggressive)  07/12/08 Comment


Get free stock alert for BAX:
Your Email Address:


Large cap medical products and services company Graphic_rating_buy BAX
India_flag_background
 9 %
 -3.24%
in 28 days
(closed on 03/26/08)
http://money.cnn.com/news/newsfeeds/articles/apwire/165fb1f58...

Baxter is a medical services company headquartered in Deerfield IL with three divisions -bioscience,renal and medical devices segment.The company has a diversfied product line, a growing market,patent protection and the cost advantage from a falling dollar.The stock is a bit richly valued at pe 23.1 pb 5.53 but is relatively debt free(0.447 debt-equity ratio).
By  Thomas George   (-4.25%  risk: moderate)  02/27/08 Comment


Baxter International (BAX) Graphic_rating_buy BAX
Robertfreedlandphoto
36%
 -5.22%
in 779 days
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. <> Please excuse my recent political digression. But I plan to share with you thoughts on other things besides stocks from time to time when I am so inspired. I look forward to your comments and responses! We certainly will not all agree about all things but I would encourage you t...
By  Robert Freedland   (-5.81%  risk: aggressive)  10/18/07 Comment





People Bullish on BAX

Steven Halpern
Tracked Blogger
56%
11 days ago

dfhutch
Analyst
N/A
2 mos ago

lila
Analyst
N/A
4 mos ago

Joseph Lazzaro
Tracked Blogger
43%
4 mos ago

tango0123
Analyst
N/A
5 mos ago


People Bearish on BAX

sdepatie
Analyst
N/A
about 1 mo ago

traderthoughts
Associate
 4 %
over 2 years ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
V Visa Inc
SIRI Sirius Satellite Radio Inc
F Ford Motor Company
FSLR First Solar Inc.
INTC Intel Corp
GLD streetTRACKS Gold

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on BAX


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Baxter International Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch